Other
Research and development funding receivable (Note 5)
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2024
Last reportedQ1 2026May 1, 2026
Metric ID:
other_grant_receivable_research_and_development_currentHistorical Data
5 periods
| Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $0 | $191M | $195M | $0 | $7M |
| QoQ Change | — | — | +2.1% | -100.0% | — |
Range$0 – $195M
Frequently Asked Questions
- What is Moderna's research and development funding receivable (note 5)?
- Moderna (MRNA) reported research and development funding receivable (note 5) of $7M in Q1 2026.